IL150431A0 - 3-phenyl-3,7-diazabicyclo [3.3.1] nonane compounds and process for their preparation and medicaments containing these compounds - Google Patents

3-phenyl-3,7-diazabicyclo [3.3.1] nonane compounds and process for their preparation and medicaments containing these compounds

Info

Publication number
IL150431A0
IL150431A0 IL15043102A IL15043102A IL150431A0 IL 150431 A0 IL150431 A0 IL 150431A0 IL 15043102 A IL15043102 A IL 15043102A IL 15043102 A IL15043102 A IL 15043102A IL 150431 A0 IL150431 A0 IL 150431A0
Authority
IL
Israel
Prior art keywords
compounds
diazabicyclo
phenyl
preparation
medicaments containing
Prior art date
Application number
IL15043102A
Other languages
English (en)
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL150431A0 publication Critical patent/IL150431A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15043102A 2001-06-28 2002-06-26 3-phenyl-3,7-diazabicyclo [3.3.1] nonane compounds and process for their preparation and medicaments containing these compounds IL150431A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10131217A DE10131217A1 (de) 2001-06-28 2001-06-28 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
IL150431A0 true IL150431A0 (en) 2002-12-01

Family

ID=7689787

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15043102A IL150431A0 (en) 2001-06-28 2002-06-26 3-phenyl-3,7-diazabicyclo [3.3.1] nonane compounds and process for their preparation and medicaments containing these compounds

Country Status (30)

Country Link
US (1) US6602880B2 (ru)
EP (1) EP1270576B1 (ru)
JP (1) JP4223237B2 (ru)
KR (1) KR20030002304A (ru)
CN (1) CN1303082C (ru)
AR (1) AR033772A1 (ru)
AT (1) ATE276254T1 (ru)
AU (1) AU781333B2 (ru)
BR (1) BR0202419A (ru)
CA (1) CA2391915C (ru)
CZ (1) CZ296878B6 (ru)
DE (2) DE10131217A1 (ru)
DK (1) DK1270576T3 (ru)
DZ (1) DZ3235A1 (ru)
ES (1) ES2229020T3 (ru)
HK (1) HK1051860A1 (ru)
HU (1) HUP0202057A3 (ru)
IL (1) IL150431A0 (ru)
MX (1) MXPA02006225A (ru)
NO (1) NO20023112L (ru)
NZ (1) NZ519811A (ru)
PL (1) PL207995B1 (ru)
PT (1) PT1270576E (ru)
RU (1) RU2299210C2 (ru)
SI (1) SI1270576T1 (ru)
SK (1) SK5862002A3 (ru)
TR (1) TR200402391T4 (ru)
TW (1) TWI256393B (ru)
UA (1) UA76707C2 (ru)
ZA (1) ZA200204063B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
ES2603856T3 (es) * 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
CN102875550B (zh) * 2011-07-12 2016-01-06 常州合全药业有限公司 1,3,7-三取代-3,7-二氮杂双环[3,3,1]壬烷衍生物及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658558A1 (de) 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4742217A (en) * 1986-06-02 1988-05-03 Honeywell Inc. Projection alignment and focusing aid
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4402931A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4402933A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
TWI256393B (en) 2006-06-11
MXPA02006225A (es) 2005-02-17
RU2299210C2 (ru) 2007-05-20
JP2003026677A (ja) 2003-01-29
ZA200204063B (en) 2003-01-23
SK5862002A3 (en) 2003-01-09
HU0202057D0 (ru) 2002-09-28
BR0202419A (pt) 2003-04-29
JP4223237B2 (ja) 2009-02-12
AR033772A1 (es) 2004-01-07
HUP0202057A3 (en) 2003-05-28
AU5064402A (en) 2003-01-02
NO20023112L (no) 2002-12-30
HUP0202057A2 (hu) 2003-01-28
KR20030002304A (ko) 2003-01-08
CA2391915A1 (en) 2002-12-28
US20030109541A1 (en) 2003-06-12
DZ3235A1 (fr) 2005-04-20
EP1270576A3 (de) 2003-03-12
CA2391915C (en) 2010-08-24
SI1270576T1 (en) 2005-02-28
TR200402391T4 (tr) 2004-12-21
DE10131217A1 (de) 2003-01-09
EP1270576B1 (de) 2004-09-15
HK1051860A1 (en) 2003-08-22
PT1270576E (pt) 2004-11-30
EP1270576A2 (de) 2003-01-02
DK1270576T3 (da) 2004-10-11
NO20023112D0 (no) 2002-06-27
ES2229020T3 (es) 2005-04-16
RU2002117066A (ru) 2004-02-20
PL354774A1 (en) 2002-12-30
NZ519811A (en) 2004-03-26
PL207995B1 (pl) 2011-02-28
CN1303082C (zh) 2007-03-07
CZ296878B6 (cs) 2006-07-12
US6602880B2 (en) 2003-08-05
CZ20021856A3 (cs) 2003-02-12
AU781333B2 (en) 2005-05-19
UA76707C2 (ru) 2006-09-15
CN1394860A (zh) 2003-02-05
DE50200996D1 (de) 2004-10-21
ATE276254T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
PL350522A1 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
IL145013A0 (en) Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0401982A3 (en) Indolizine derivates, process for their preparation and pharmaceutical compositions containing the compounds
HUP0303524A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
IL164857A (en) 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0204410A3 (en) Pyrimidine-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0401292A3 (en) Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
HUP0400810A3 (en) Substituted 1-oxa-2,8-diaza-spiro[4.5]dec-2-ene derivatives, process for their preparation, their use and pharmaceutical compositions containing them
MXPA03001483A (es) Heterociclos biciclicos medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
ZA200003702B (en) Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
MXPA03001510A (es) Heterociclos biciclicos, medicamentos que contiene estos compuestos, su empleo y procedimientos para su preparacion.
EP1651651A4 (en) NANOPARTICLES CONTAINING CUCURBITURIL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD FOR THE PRODUCTION THEREOF
HUP0104779A3 (en) Antihistaminic spiro compounds, process for their preparation and medicaments containing them
MXPA03009206A (es) FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0402282A3 (en) Triazolo[1,5a] quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
HK1050003A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them.
ZA200205596B (en) Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204063B (en) 3-phenyl - 3,7 - diazabicyclo [3.3.1] nonane compounds and process for their preparation and medicaments containing these compounds.
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
ZA200110314B (en) Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use